Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 02, 2026 08:00 ET | Source: Jupiter Neurosciences, Inc.

Jupiter Neurosciences to Present at BIO Investment and Growth Summit 2026

Advancing FDA-Cleared Phase IIa Parkinson’s Program Targeting Neuroinflammation Dual-Path Strategy Combines Clinical Development with Revenue-Generating Nugevia™ JUPITER, FL, March 02, 2026 (GLOBE...
December 11, 2025 08:08 ET | Source: Bleichmar Fonti & Auld

MLTX INVESTOR NOTICE: MoonLake Immunotherapeutics Stock Dropped 90% after Drug Trial Results; Contact BFA Law about the Pending Securities Class Action

MoonLake Immunotherapeutics Stock Dropped 90% after Drug Trial Results; Contact BFA Law about the Pending Securities Class Action
November 29, 2025 06:38 ET | Source: Bleichmar Fonti & Auld

MLTX STOCK: Lose Money on Your MoonLake Immunotherapeutics Investment? Contact BFA Law about the Pending Securities Class Action before December 15 Deadline

MoonLake Immunotherapeutics investors that lost money are notified to contact BFA before the December 15, 2025 securities fraud class action deadline.
November 27, 2025 07:18 ET | Source: Bleichmar Fonti & Auld

MLTX INVESTMENT: MoonLake Immunotherapeutics Investors with Losses may have Rights in Securities Class Action – Contact BFA Law by December 15 Deadline

MoonLake Immunotherapeutics investors that lost money are notified to contact BFA before the December 15, 2025 securities fraud class action deadline.
November 25, 2025 08:33 ET | Source: Bleichmar Fonti & Auld

INVESTOR REMINDER: Important MoonLake Immunotherapeutics Securities Class Action Deadline Approaching on December 15 for Investors with Losses – Contact BFA Law

MoonLake Immunotherapeutics investors that lost money are notified to contact BFA before the December 15, 2025 securities fraud class action deadline.
November 23, 2025 07:38 ET | Source: Bleichmar Fonti & Auld

MLTX COURT ALERT: MoonLake Immunotherapeutics Investors that Lost Money May have been Affected by Fraud -- Contact BFA Law by December 15

MoonLake Immunotherapeutics investors that lost money are notified to contact BFA before the December 15, 2025 securities fraud class action deadline.
November 17, 2025 08:08 ET | Source: Bleichmar Fonti & Auld

MLTX STOCK LOSS: MoonLake Immunotherapeutics Faces Securities Fraud Class Action due to Drug Trial Results – Contact BFA Law if You Suffered Losses

MoonLake Immunotherapeutics investors that lost money are notified to contact BFA before the December 15, 2025 securities fraud class action deadline.
October 23, 2025 17:24 ET | Source: kneat.com, inc.

Kneat to Announce 2025 Third-Quarter Financial Results November 12, 2025

Kneat to release Q3 2025 financial results on November 12, 2025, host earnings call November 13, 2025.
August 25, 2025 09:00 ET | Source: Gevo, Inc.

Gevo to Participate in Virtual Fireside Chat

ENGLEWOOD, Colo., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO) announced today that Leke Agiri, Gevo’s Chief Financial Officer, and Eric Frey, Gevo’s Vice President of Finance and...
July 30, 2025 04:00 ET | Source: Rakovina Therapeutics Inc

Rakovina Therapeutics Highlights Long-Standing Collaboration with the University of British Columbia and the Vancouver Prostate Centre

VANCOUVER, British Columbia, July 30, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing cancer...